#AstraZeneca for the first time admits its Covishield vaccine may lead to rare side effect
16148 Tuesday, 30 April, 2024, 23:24 AstraZeneca has admitted for the first time in court documents that its Covid-19 vaccine, sold globally under the brand names Covishield and Vaxzevria among others, may lead to a rare side-effect. Covishield can cause, in rare cases, a condition that leads to blood clots and low platelet count, the vaccine-maker has said in court documents. This condition is known as Thrombosis with Thrombocytopenia Syndrome (TTS). Covishield was produced by the Serum Institute of India and widely administered in the country. AstraZeneca is facing a class action lawsuit in the UK over claims that its vaccine caused deaths and severe injuries in several cases. |
'Out of darkness, can come light': Kate's message in full (video)
118409.09.2024, 22:12Over 70 factories in Ashulia shut down amid workers’ protests
176004.09.2024, 20:24First children in Gaza given polio vaccine
230301.09.2024, 00:30Mpox cases are rising in Australia’s eastern states
440316.08.2024, 10:48WHO: Monkey pox, global public health emergency
459615.08.2024, 11:12Chinese network accused of stealing thousands of corpses to use bones for dental grafts
505409.08.2024, 19:24,,Since August 5, officially I stopped my work at the National Center for Disease Control and Prevention of the Ministry of Health,,: Gayane Sahakyan
276506.08.2024, 20:12Heart transplant breakthrough as human receives titanium heart for the first time (video)
625428.07.2024, 23:42